MTOR and hepatocellular carcinoma: Previous studies in our laboratory showed that the canonical signaling pathway involving the mechanistic target of rapamycin (mTOR) and, more specifically, mTOR complex 1 (mTORC1), is activated during the early stages of focal lesion development in the Solt-Farber model of progenitor marker-positive HCC [2, 3].